W630

Radiopharmazeutika und Präklinische Studien
IDI:(DE-He78)W630-20160331

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
European journal of nuclear medicine and molecular imaging nn, nn () [10.1007/s00259-025-07427-4]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Review Article)  ;  ;  ;  ;
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.
Pharmaceuticals 18(6), 906 () [10.3390/ph18060906]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;
Structure–Activity Relationships and Biological Insights into PSMA-617 and Its Derivatives with Modified Lipophilic Linker Regions
ACS omega 10(7), 7077-7090 () [10.1021/acsomega.4c10142]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;
Concept validation of separations for thorium-based radionuclide generator systems for medical application
Frontiers in Nuclear Engineering 3, - () [DOI:10.5445/IR/1000176410]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Preprint  ;  ;  ;  ;  ;  ;
Semantic Representation of Preclinical Data in Radiation Oncology.
Journal of biomedical semantics () [10.21203/rs.3.rs-5373454/v1] special issue: "ICBO Thematic Series Collection"  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Letter)  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
ACS medicinal chemistry letters 15(11), 1970–1978 () [10.1021/acsmedchemlett.4c00324]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Review Article)  ;  ;  ;  ;  ;  ;  ;
Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy.
Pharmaceuticals 17(8), 1031 () [10.3390/ph17081031]  GO DBCoverage  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;
Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
Pharmaceuticals 17(4), 513 () [10.3390/ph17040513]  GO DBCoverage  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;
Synthesis of tritium-labeled Lu-PSMA-617: Alternative tool for biological evaluation of radiometal-based pharmaceuticals.
Applied radiation and isotopes 197, 110819 () [10.1016/j.apradiso.2023.110819]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Review Article)  ;
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.
Pharmaceuticals 15(10), 1292 () [10.3390/ph15101292]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 


 Record created 2021-08-02, last modified 2022-03-18



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)